Charels Drew, MD, earned his doctor of medical science degree at VP&S for research that led to the first large-scale blood bank program in the United States.
A combination of a diabetes drug and a PI3K inhibitor may have potential in preventing melanoma from spreading to the liver, according to a study from Columbia cancer researchers.
Lucky Tran, a science communicator at Columbia, called the potential end of five-day isolation periods “a reckless anti-public-health policy that goes against science and encourages disease spread.”
The CUIMC Healthy Aging Initiative will host its first Healthspan Extension Summit later this spring, highlighting the work of CUIMC researchers in basic, clinical, and population health sciences.
An inventor of new ways to manipulate molecules inside living cells to treat a wide range of conditions was inspired to become a scientist after reading the mysteries of Sherlock Holmes.
Betsy Ladyzhets spoke to Melissa Stockwell, a pediatrician and public health researcher at Columbia University who was one of the lead authors on the study and helps lead RECOVER’s pediatric research.
At the CUIMC Well-Being Fair, employees participated in well-being activities and received information and resources related to well-being, heart health, mindfulness, and relaxation.
Alade McKen, chief diversity, equity, and inclusion officer for staff at CUIMC, discusses the top priorities for 2024 and the role DEI plays during moments of upheaval.
